Your browser doesn't support javascript.
loading
Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain.
Martinón-Torres, Federico; de Miguel, Ángel Gil; Ruiz-Contreras, Jesús; Vallejo-Aparicio, Laura A; García, Andrea; Gonzalez-Inchausti, María C; de Gomensoro, Eduardo; Kocaata, Zeki; Gabás-Rivera, Clara; Comellas, Marta; Prades, Miriam; Lizán, Luis.
Afiliación
  • Martinón-Torres F; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • de Miguel ÁG; Genetics, Vaccines and Infections Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago, University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Ruiz-Contreras J; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • Vallejo-Aparicio LA; Department of Preventive Medicine and Public Health, Universidad Rey Juan Carlos, Madrid, Spain.
  • García A; Department of Pediatrics, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Gonzalez-Inchausti MC; Department of Pediatrics, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
  • de Gomensoro E; GSK, Madrid, Spain. laura.a.vallejo@gsk.com.
  • Kocaata Z; GSK, Madrid, Spain.
  • Gabás-Rivera C; GSK, Madrid, Spain.
  • Comellas M; GSK, Madrid, Spain.
  • Prades M; GSK, Wavre, Belgium.
  • Lizán L; Outcomes'10, Castellón, Spain.
Infect Dis Ther ; 12(1): 157-175, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36367677
INTRODUCTION: Immunization is the most effective strategy for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB); however, parents need to weigh the risk-benefit and financial impact of immunizing their children against MenB in the absence of a national immunization program (NIP). This study aimed to explore societal preferences (of parents and pediatricians) regarding the attributes of a MenB vaccine in Spain. METHODS: A discrete choice experiment (DCE) based on cross-sectional surveys was carried out to determine preferences. A literature review and scientific committee determined the six attributes related to the MenB vaccine included in the DCE: vaccination age, cost, duration, percentage of protection, adverse events probability, and expert/authority recommendation. Data were analyzed using a mixed logit model. Relative importance (RI) of attributes was calculated and compared between parents and pediatricians. RESULTS: A total of 278 parents [55.8% female, mean age 40.4 (standard deviation, SD 7.3) years] and 200 pediatricians [73.0% female, mean age 45.8 (SD 12.9) years] answered the DCE. For parents, the highest RI was attributed to vaccine cost, expert/authority recommendation, and percentage of protection (26.4%, 26.1%, and 22.9%, respectively), while for pediatricians the highest RI was assigned to percentage of protection, expert/authority recommendation, and vaccination age (27.2%, 23.7%, and 22.6%, respectively). Significant differences between parents and pediatricians were found in the RI assigned to all attributes (p < 0.001), except for vaccine recommendation. CONCLUSION: In the decision regarding MenB vaccination, cost was a driver in parental decision-making but had a low RI for pediatricians and, conversely, vaccination age was highly valued by pediatricians but was the attribute with least importance for parents. Despite these differences, expert/authority recommendation and percentage of protection were essential criteria for both groups. These results provide relevant information about MenB vaccination, highlighting the importance of considering societal preferences for NIP inclusion.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Infect Dis Ther Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Infect Dis Ther Año: 2023 Tipo del documento: Article País de afiliación: España